Condition: Metastatic Colorectal Cancer (mCRC) · Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Colorectal cancer (CRC) is the second leading cause of cancer-related death in the United States and Europe. Although selected patients with oligometastatic CRC undergo systemic therapy and surgery/local ablative therapy in curative intent, the treatment approach for the majority of metastatic CRC (mCRC) patients remains palliative with a median overall survival (OS) ranging between 9-38 months depending on various prognostic and predictive factors. Particularly in advanced stages (in the third line of therapy and beyond), interesting and promising results have recently been achieved with various treatment approaches. The aim of this registry is to establish a disease-specific registry to evaluate the treatment landscape of patients with mCRC who have already received at least two lines of therapy.
This description comes directly from the study's public registry record.
Daniela Wolkersdorfer, Dr. · +436626404412 · office@agmt.at
Always discuss trial participation with your own doctor first.
| Ordensklinikum Linz, BHS - Interne I | Linz, Austria | Recruiting |
| KUK Linz - Med Campus III.: Univ.-Klinik für Hämatologie und Internistische Onkologie | Linz, Austria | Recruiting |
| LKH Feldkirch: Innere Medizin II/ Interne E (Hämatologie und Onkologie) | Rankweil, Austria | Recruiting |
| Department of Internal Medicine III, Paracelsus Medical University Salzburg | Salzburg, Austria | Recruiting |
| Klinikum Steyr: Innere Medizin II: Onkologie, Gastroenterologie, Angiologie | Steyr, Austria | Recruiting |
| Klinikum Wels: Abteilung für Innere Medizin IV | Wels, Austria | Recruiting |
| KH Zams: Innere Medizin Internistische Onkologie und Hämatologie | Zams, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06678919